Lynch-like syndrome is as frequent as Lynch syndrome in early-onset nonfamilial nonpolyposis colorectal cancer

被引:16
|
作者
Antelo, Marina [1 ,2 ]
Golubicki, Mariano [1 ]
Roca, Enrique [1 ]
Mendez, Guillermo [1 ]
Carballido, Marcela [1 ]
Iseas, Soledad [1 ]
Cuatrecasas, Miriam [3 ]
Moreira, Leticia [3 ]
Sanchez, A. [3 ]
Carballal, S. [3 ]
Castells, Antoni [3 ]
Boland, Clement R. [4 ]
Goel, Ajay [5 ,6 ]
Balaguer, Francesc [3 ]
机构
[1] Hosp Gastroenterol Dr CB Udaondo, Oncol Sect, Buenos Aires, DF, Argentina
[2] Natl Univ Lanus, Collect Hlth Inst, Buenos Aires, DF, Argentina
[3] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Dept Gastroenterol,Hosp Clin, Barcelona, Spain
[4] UCSD Sch Med, Dept Med, San Diego, CA USA
[5] Baylor Univ, Med Ctr, Baylor Scott White Res Inst, Ctr Gastrointestinal Res,Ctr Translat Genom & Onc, Dallas, TX 75246 USA
[6] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX 75246 USA
关键词
MISMATCH-REPAIR DEFICIENCY; YOUNG-PATIENTS; MICROSATELLITE INSTABILITY; MUTATION CARRIERS; GENE-MUTATIONS; GERMLINE; PREVALENCE; SUSCEPTIBILITY; IDENTIFICATION; FEATURES;
D O I
10.1002/ijc.32160
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Early-onset (<50 years-old) nonpolyposis nonfamilial colorectal cancer (EO NP NF CRC) is a common clinical challenge. Although Lynch syndrome (LS) is associated with EO CRC, the frequency of this syndrome in the EO NF cases remains unknown. Besides, mismatch repair deficient (MMRd) CRCs with negative MMR gene testing have recently been described in up to 60% of cases and termed "Lynch-like syndrome" (LLS). Management and counseling decisions of these patients are complicated because of unconfirmed suspicions of hereditary cancer. To define the prevalence of MMR deficient CRCs, LS and LLS in patients with EO NP NF CRC, we recruited 102 patients with a first diagnosis of NP NF CRC <= 50 years old during 2003-2009 who underwent genetic counseling at our institution in Argentina. Tumor immunohistochemical (IHC) MMR for protein expression and microsatellite instability (MSI) status were evaluated, and in those with loss of MLH1 expression by IHC, somatic BRAF V600E mutation and both somatic and germline MLH1 methylation levels were studied. Tumors characterized as MMRd without somatic BRAF mutation nor MLH1 methylation were sent for germline analysis. Twenty one (20.6%) tumors were MMRd. Fourteen of 16 putative LS cases underwent germline testing: 6 pathogenic mutations were identified and 8 cases had no identifiable pathogenic mutations. The prevalence of LS and LLS in this cohort was 5.8% (6/102) and 7.8% (8/102), respectively. As a conclusion we found that 20% of patients with EO NP NF CRC have MMRd tumors, and at least half of these are likely to have LLS.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 50 条
  • [31] Lynch-like Syndrome: Potential Mechanisms and Management
    Martinez-Roca, Alejandro
    Giner-Calabuig, Mar
    Murcia, Oscar
    Castillejo, Adela
    Soto, Jose Luis
    Garcia-Heredia, Anabel
    Jover, Rodrigo
    CANCERS, 2022, 14 (05)
  • [32] Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Criteria for Identification and Management
    Gregory Kouraklis
    Evangelos P. Misiakos
    Digestive Diseases and Sciences, 2005, 50 : 336 - 344
  • [33] Hereditary nonpolyposis colorectal cancer (Lynch syndrome): Criteria for identification and management
    Kouraklis, G
    Misiakos, EP
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (02) : 336 - 344
  • [34] Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome)
    Miguel A. Rodriguez-Bigas
    Gabriela Möeslein
    Familial Cancer, 2013, 12 : 295 - 300
  • [35] Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome)
    Rodriguez-Bigas, Miguel A.
    Moeeslein, Gabriela
    FAMILIAL CANCER, 2013, 12 (02) : 295 - 300
  • [36] INTERVAL CANCERS IN HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER (LYNCH SYNDROME)
    VASEN, HFA
    NAGENGAST, FM
    KHAN, PM
    LANCET, 1995, 345 (8958): : 1183 - 1184
  • [37] Hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay -: Reply
    Sarroca, C
    Alfano, N
    Bendin, GT
    Della Valle, A
    Dominguez, A
    Quadrelli, R
    Vaglio, A
    Mechoso, B
    Tinley, ST
    Harty, AE
    Lynch, JF
    Franklin, BA
    Smyrk, TC
    Lynch, HT
    Kristo, P
    Peltomäki, P
    DISEASES OF THE COLON & RECTUM, 2000, 43 (03) : 361 - 362
  • [38] Clinical Description of the Lynch Syndrome [Hereditary Nonpolyposis Colorectal Cancer (HNPCC)]
    H. F. A. Vasen
    Familial Cancer, 2005, 4 : 219 - 225
  • [39] Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]
    Vasen, HFA
    FAMILIAL CANCER, 2005, 4 (03) : 219 - 225
  • [40] Implication of DNA repair genes in Lynch-like syndrome
    Xicola, Rosa M.
    Clark, Julia R.
    Carroll, Timothy
    Alvikas, Jurgis
    Marwaha, Priti
    Regan, Maureen R.
    Lopez-Giraldez, Francesc
    Choi, Jungmin
    Emmadi, Rajyasree
    Alagiozian-Angelova, Victoria
    Kupfer, Sonia S.
    Ellis, Nathan A.
    Llor, Xavier
    FAMILIAL CANCER, 2019, 18 (03) : 331 - 342